McFarland, Henry F.
https://orcid.org/0000-0002-8448-8503
Mayo Clinic
From the Outpatient Clinic Neurology-Neurosurgery (Dr. Kappos), University Hospital Basel, Switzerland; Department of Neurology (Dr. Weinshenker), Mayo Clinic and Foundation, Rochester, MN; Department of Neurology (Dr. Pozzilli), University of Rome “La Sap
Citations 3
Interferon beta-1b in secondary progressive MS
Kappos, Ludwig , Weinshenker, Brian G. , Pozzilli, Carlo , Thompson, Alan J. , Beckmann, K., Polman, Chris H. , McFarland, Henry F. , Dahlke, Frank , Weinshenker, Brian G , Pozzilli, Carlo
Neurology | May 13, 2012 | Volume: 63 | Issue: 10 | Pages: 1779-1787
Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure
Stone, Lael A., Frank, Joseph A., Albert, Paul S. , Bash, C., Maloni, Heidi , McFarland, Henry F. , Calabresi, Peter A.
Neurology | May 13, 2012 | Volume: 49 | Issue: 3 | Pages: 862-869
Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI
Stone, Lael A., Bash, C., Frank, Joseph A. , McFarland, Henry F. , Calabresi, Peter A.
Neurology | May 13, 2012 | Volume: 48 | Issue: 5 | Pages: 1446-1448